Table:
begin	end	state
1	11	non-cytoplasmic
12	35	transmembrane
36	40	cytoplasmic
41	60	transmembrane
61	64	cytoplasmic
65	65	non-cytoplasmic
66	92	transmembrane
93	98	non-cytoplasmic
99	115	cytoplasmic
116	117	non-cytoplasmic
118	148	transmembrane
149	152	non-cytoplasmic
153	153	cytoplasmic
154	179	transmembrane
180	185	cytoplasmic
186	186	non-cytoplasmic
187	192	cytoplasmic
193	217	transmembrane
218	220	cytoplasmic
221	222	non-cytoplasmic
223	245	transmembrane
246	246	cytoplasmic
247	251	non-cytoplasmic
252	270	transmembrane
271	281	cytoplasmic
282	301	non-cytoplasmic
302	306	cytoplasmic
307	326	transmembrane
327	330	cytoplasmic
331	348	transmembrane
349	376	non-cytoplasmic
377	399	transmembrane
400	410	cytoplasmic
411	432	transmembrane
433	438	non-cytoplasmic
439	464	transmembrane
465	536	cytoplasmic
537	558	transmembrane
559	560	non-cytoplasmic

Input:
>17053 FitnessBrowser__Keio:17053
MVTWTQMYMPMGGLGLSALVALIPIIFFFVALAVLRLKGHVAGAITLILSILIAIFAFKM
PIDMAFAAAGYGFIYGLWPIAWIIVAAVFLYKLTVASGQFDIIRSSVISITDDQRLQVLL
IGFSFGALLEGAAGFGAPVAITGALLVGLGFKPLYAAGLCLIANTAPVAFGALGVPILVA
GQVTGIDPFHIGAMAGRQLPFLSVLVPFWLVAMMDGWKGVKETWPAALVAGGSFAVTQFF
TSNYIGPELPDITSALVSIVSLALFLKVWRPKNTETAISMGQSAGAMVVNKPSSGGPVPS
EYSLGQIIRAWSPFLILTVLVTIWTMKPFKALFAPGGAFYSLVINFQIPHLHQQVLKAAP
IVAQPTPMDAVFKFDPLSAGGTAIFIAAIISIFILGVGIKKGIGVFAETLISLKWPILSI
GMVLAFAFVTNYSGMSTTLALVLAGTGVMFPFFSPFLGWLGVFLTGSDTSSNALFGSLQS
TTAQQINVSDTLLVAANTSGGVTGKMISPQSIAVACAATGMVGRESELFRYTVKHSLIFA
SVIGIITLLQAYVFTGMLVS

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server